Evidence map›Paper›PMID 39925348›Full record

ArticleHeliyon2025

Camel milk and D-allulose synergistically improved camel dairy flavor and alleviated insulin resistance of human HepG2 cells.

Tuerxunnayi Aili, Zhaoxu Xu, Chen Liu, Jie Yang, Haitao Yue

Abstract read
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tuerxunnayi AiliCollege of Life Science and Technology, Xinjiang University, 830046, China.
Zhaoxu XuCollege of Intelligent Science and Technology, Xinjiang University, 830046, China.
Chen LiuCollege of Biotechnology, Tianjin University of Science and Technology, 300457, China.
Jie YangCollege of Life Science and Technology, Xinjiang University, 830046, China.
Haitao YueCollege of Life Science and Technology, Xinjiang University, 830046, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Camel milk is a dairy product widely consumed in desert and semi-arid areas, with high nutritional value and potential for auxiliary medical treatment. It has unique efficacy and a gamey taste, and exploring its functional factors and making camel milk more easily accepted by the public has become a research hotspot. This study mainly investigated the protein components in camel milk that may play a role in alleviating insulin resistance by observing the cell activity, glucose consumption, and morphological changes of the treatment group. Further research was conducted on the potential synergistic hypoglycemic effect of camel milk and D-allulose, and a formula was ultimately determined to enhance the flavor of camel milk through a series of sensory evaluation experiments. The optimal concentration for the treatment of insulin resistance (IR) was identified as 4 mg/mL of CWP4 combined with 1 mg/mL of D-allulose for a period of 12 h. The addition of D-allulose at a ratio of 1:36 in camel milk has been observed reduce the odoriferous properties of the camel milk, while simultaneously retaining the majority of other desirable flavors. This research helps to concentrate the functional protein factors in camel milk, promote the intensive processing of camel milk, and develop new camel milk health products. These products may help patients with diabetes stabilize their blood sugar levels in daily life, thus enriching their diet, and may expand the market of camel milk.

Indexed as

Alleviated insulin resistanceCamel milkD-alluloseFood additivesHypoglycemic

Identifiers

PMID39925348
PMCPMC11804550

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.